Then, a simple and specific diagnosis model based on three plasma biomarkers (p-Tau181, Aβ42/Aβ40, GFAP) and ApoE genotype was validated in a cohort from the same cognitive impairment unit. The gene discussed is APOE; the disease is Cognitive impairment.